Format

Send to

Choose Destination
Future Microbiol. 2014;9(10):1165-77. doi: 10.2217/fmb.14.66.

Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.

Author information

1
Antimicrobials Research Group, Institute of Microbiology & Infection, School of Immunity & Infection, College of Medical & Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.

Abstract

Gram-negative bacteria express a plethora of efflux pumps that are capable of transporting structurally varied molecules, including antibiotics, out of the bacterial cell. This efflux lowers the intracellular antibiotic concentration, allowing bacteria to survive at higher antibiotic concentrations. Overexpression of some efflux pumps can cause clinically relevant levels of antibiotic resistance in Gram-negative pathogens. This review discusses the role of efflux in resistance of clinical isolates of Gram-negative bacteria, the regulatory mechanisms that control efflux pump expression, the recent advances in our understanding of efflux pump structure and how inhibition of efflux is a promising future strategy for tackling multidrug resistance in Gram-negative pathogens.

KEYWORDS:

AcrAB; MarA; MexAB; RamA; TolC; efflux inhibitor; regulation; two component regulatory system

PMID:
25405886
DOI:
10.2217/fmb.14.66
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center